Pure Global

ARUMAMED T3 (Total Triiodothyronine) Rapid Quantitative Test (Immunofluorescence Assay) - Indonesia BPOM Medical Device Registration

ARUMAMED T3 (Total Triiodothyronine) Rapid Quantitative Test (Immunofluorescence Assay) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101322820. The device is manufactured by AEHEALTH LIMITED from United Kingdom, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. ARDIKHA UMRAN ABADI.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
ARUMAMED T3 (Total Triiodothyronine) Rapid Quantitative Test (Immunofluorescence Assay)
Analysis ID: AKL 20101322820

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

AEHEALTH LIMITED

Country of Origin

United Kingdom

Authorized Representative

PT. ARDIKHA UMRAN ABADI

AR Address

Jl. Bintara VIII Nomor 100 A

Registration Date

Mar 26, 2023

Expiry Date

Mar 17, 2026

Product Type

Clinical Chemistry Test System

Total triiodothyronine test system (kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing